myirislogo
14 October, 2019 11:12 IST
My Last 5 Scrips
Company BSE Price (Rs) % Chg
Tata Motors 127.70 5.23
State Bank O 257.00 0.98
Tata Stl 350.60 3.30
Ong Corp 132.40 2.56
Icici Bank 429.30 0.21
Clear All Clear Last
   
NSE Live
Nifty Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Nse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
BSE Live
BSE30 Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Bse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
Watch
Sector Watch
Economy Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Research
Research Reports
Snapshot-Unichem Laboratories Limited
Unichem Laboratories Limited
Sector:Pharmaceuticals Pharmaceuticals - Formulations
BSE:506690NSE:UNICHEMLABBloomberg:UL@INReuters:UNLB.BO
Market Lot: 1Face Value: 2ISIN Demat: INE351A01035
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
24-DEC-18 Unichem Laboratories has received final ANDA approval for its Pramipexole Dihydrochloride Tablets, 0.125 mg, 0.25 mg, 0.5 mg, 0.75 mg, 1 mg and 1.5 mg 12-DEC-18 Unichem Laboratories has received tentative approval for its ANDA, Tadalafil Tablets, 2.5 mg, 5 mg, 10 mg and 20 mg from the USFDA for a generic version of Eli Lilly's Cialis, 2.5 mg, 5 mg, 10 mg and 20 mg. 04-JUL-18 Unichem Laboratories has received final ANDA approval for...   More..
Business Profile Future Plans
CEO Talk
`I am yet to come across a brand sale where the buyer has benefited`, says he, being very cautious on acquisition plans.   Dr Prakash A Mody
One To One
Recent news
Latest News
Unichem Lab gets tentative nod for Tadalafil tablets  -IRIS 12-Dec-18
Previous

More


Brief Financials (in Rs. Mn.)Detailed Quarterly
Period ending (months)30-Jun-2019(3)31-Mar-2019 (12)31-Mar-2018(12)
Net sales 2325.219677.399015.60
Other Income279.841015.42671.89
Total Income2605.0510692.819687.49
Cost of goods sold-2675.39-10908.618982.22
OPBDIT5280.4421601.42705.27
PAT4.6487.99-84.00
Gross Block---
Equity capital-0.00140.67
EPS (Rs.)-0.00-
DPS (Rs.)---
BV (Rs.)---
P/E range (x)-NA-
Debt / Equity (x)---
Operating margin (% of OI)202.7202.0 7.3
Net margin (% of OI) 0.2 0.8-0.9
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
Unichem Bhavan
Prabhat Estate
Off S V Road
Jogeshwari (West)
Mumbai
Maharashtra-400 102
PHONE
(022) 6688 8333
FAX
(022) 2679 4089/ 2678 4391
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer